H2-antagonist in IgE-mediated type I hypersensitivity reactions: what literature says so far?
- PMID: 33849573
- PMCID: PMC8042967
- DOI: 10.1186/s12948-021-00143-y
H2-antagonist in IgE-mediated type I hypersensitivity reactions: what literature says so far?
Abstract
Histamine is a monoamine synthesized from the amino acid histidine that is well-known for its role in IgE-mediated anaphylaxis but has shown pleiotropic effects on the immune system, especially in order to promote inflammatory responses. H1-receptor antagonist are common drugs used in mild/moderate allergic reactions whereas H2-receptor antagonist are commonly administered in gastric ulcer but showed some properties in allergy too. The EAACI guidelines for diagnosis and treatment of anaphylactic reactions recommend their use as third-line therapy in adjunct to H1-antagonists. The purpose of this article is to produce a complete summary of findings and evidence known so far about the usefulness of H2-receptor antagonist in allergic reactons.
Keywords: Allergy; H2-receptor antagonist; Histamine; Type-I hypersensitivity reaction.
Conflict of interest statement
The authors declare that they have no competing interests.
Similar articles
-
The effects of H1 and H2 receptor antagonism on the response of monkey skin to intradermal histamine, reverse-type anaphylaxis, and passive cutaneous anaphylaxis.J Allergy Clin Immunol. 1979 Jun;63(6):376-82. doi: 10.1016/0091-6749(79)90209-4. J Allergy Clin Immunol. 1979. PMID: 36420
-
H1- and H2-antagonists in allergic and pseudoallergic diseases.Clin Exp Allergy. 1990 Aug;20 Suppl 2:43-9. doi: 10.1111/j.1365-2222.1990.tb02460.x. Clin Exp Allergy. 1990. PMID: 1977507 Review.
-
[Allergic reactions and pseudoallergies in surgical interventions with general anesthesia].Allergol Immunopathol (Madr). 2000 Jan-Feb;28(1):24-36. Allergol Immunopathol (Madr). 2000. PMID: 10757856 Review. Spanish.
-
Reclassifying Anaphylaxis to Neuromuscular Blocking Agents Based on the Presumed Patho-Mechanism: IgE-Mediated, Pharmacological Adverse Reaction or "Innate Hypersensitivity"?Int J Mol Sci. 2017 Jun 7;18(6):1223. doi: 10.3390/ijms18061223. Int J Mol Sci. 2017. PMID: 28590439 Free PMC article. Review.
-
Use of prophylactic combined H1 and H2 antagonists reduces mortality in chymopapain anaphylaxis.Ann Fr Anesth Reanim. 1985;4(2):221-4. doi: 10.1016/S0750-7658(85)80204-5. Ann Fr Anesth Reanim. 1985. PMID: 2860828 Clinical Trial.
Cited by
-
A Rare Incidence of Sweating Sickness-Like Symptoms in a Crossbred Holstein Friesian Cow in Chattogram, Bangladesh.Case Rep Vet Med. 2023 Jun 6;2023:6470133. doi: 10.1155/2023/6470133. eCollection 2023. Case Rep Vet Med. 2023. PMID: 37324955 Free PMC article.
-
IgE and non-IgE-mediated pathways in anaphylaxis.Semin Immunopathol. 2025 Aug 13;47(1):34. doi: 10.1007/s00281-025-01056-7. Semin Immunopathol. 2025. PMID: 40802080 Free PMC article. Review.
-
Clinical characteristics and risk factors for escalation to anaphylaxis from non-severe drug hypersensitivity reaction.Clin Transl Allergy. 2025 Apr;15(4):e70047. doi: 10.1002/clt2.70047. Clin Transl Allergy. 2025. PMID: 40263639 Free PMC article.
References
-
- Baumer W, Rossbach K. [Histamine as an immunomodulator] J Dtsch Dermatol Ges. 2010;8(7):495–504. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources